Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers

Journal of Substance Abuse Treatment

Volumn 60, Issue , 2016, Pages 6-13

  LaBelle, Colleen T ^a,b   Han, Steve Choongheon ^b   Bergeron, Alexis ^a   Samet, Jeffrey H ^a,b,c  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Access to treatment; Buprenorphine; Nurse care manager; Opioid agonist therapy; Opioid use disorder; Waivered physicians

Indexed keywords

BUPRENORPHINE; OPIATE; NARCOTIC AGENT;

ADULT; ARTICLE; CLINICAL PRACTICE; DRUG EFFICACY; DRUG OVERDOSE; DRUG SCREENING; EVIDENCE BASED PRACTICE; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEALTH CENTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OPIATE ADDICTION; PATIENT MONITORING; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SCREENING TEST; TREATMENT DURATION; UNITED STATES; WITHDRAWAL SYNDROME; AMBULATORY CARE; COOPERATION; MASSACHUSETTS; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; ORGANIZATION AND MANAGEMENT; PROCEDURES; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; AMBULATORY CARE; BUPRENORPHINE; COMMUNITY HEALTH CENTERS; COOPERATIVE BEHAVIOR; FEMALE; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; YOUNG ADULT;

EID: 84952638737     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2015.06.010     Document Type: Article

References (23)

1. Alford D.P., LaBelle C.T., Kretsch N., Bergeron A., Winter M., Botticelli M., et al. Collaborative care of opioid-addicted patients in primary care using buprenorphine: Five-year experience. Archives of Internal Medicine 2011, 171(5):425-431.
2. Alford D.P., LaBelle C.T., Richardson J.M., O'Connell J.J., Hohl C.A., Cheng D.M., et al. Treating homeless opioid dependent patients with buprenorphine in an office-based setting. Journal of General Internal Medicine 2007, 22(2):171-176.
3. Barry D.T., Irwin K.S., Jones E.S., Becker W.C., Tetrault J.M., Sullivan L.E., et al. Integrating buprenorphine treatment into office-based practice: A qualitative study. Journal of General Internal Medicine 2009, 24(2):218-225.
4. Center for Disease Control and Prevention Prescription drug overdose in the United States: Fact sheet Retrieved from. http://www.cdc.gov/homeandrecreationalsafety/overdose/facts.html.
5. Center for Substance Abuse Treatment Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. DHHS publication no. (SMA) 07-3939 2004, SAMHSA, Rockville, MD.
6. Center for Substance Abuse Treatment Buprenorphine: A guide for nurses. DHHS pub. no. (SMA) 09-4376) 2009, SAMHSA, Rockville, MD.
7. Drug addiction treatment act of 2000, calendar no. 740 2000.
8. Haddad M.S., Zelenev A., Altice F.L. Integrating buprenorphine maintenance therapy into federally qualified health centers: Real-world substance abuse treatment outcomes. Drug and Alcohol Dependence 2013, 131(1):127-135.
9. Kaiser Family Foundation Total professionally active physicians Retrieved from. http://kff.org/other/state-indicator/total-active-physicians/.
10. Kissin W., McLeod C., Sonnefeld J., Stanton A. Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence. Journal of Addictive Diseases 2006, 25(4):91-103.
11. Knapp H., Anaya H.D. Implementation science in the real world: A streamlined model. Journal for Healthcare Quality 2012, 34(6):27-35.
12. Massachusetts Behavioral Health Partnership Health New England be healthy provider manual Retrieved from. http://www.masspartnership.com/HNE/HNEProvManual.aspx.
13. MassHeatlh MassHealth provider manual series community health center manual 2015, MassHealth.
14. McLellan A.T., Lewis D.C., O'Brien C.P., Kleber H.D. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA: the journal of the American Medical Association 2000, 284(13):1689-1695.
15. Rep Bliley T. Drug addiction treatment act of 2000 2000, Calendar No. 740.
16. SAMHSA Drug addiction treatment act of 2000 Retrieved from. http://buprenorphine.samhsa.gov/fulllaw.html.
17. SAMHSA Center for Behavioral Health Statistics and Quality Treatment episode data set (TEDS) 2002-2012. National admissions to substance abuse treatment services. BHSIS series S-71, HHS publication no. (SMA) 14-4850) 2014, SAMHSA, Rockville, MD.
18. Substance Abuse and Mental Health Services Administration Medicaid coverage and financing of medications to treat alcohol and opioid use disorders. HHS publication no. SMA-14-4854 2014, Substance Abuse and Mental Health Services Administration, Rockville, MD.
19. Substance Abuse and Mental Health Services Administration Results from the 2013 national survey on drug use and health: Summary of national findings. NSDUH series H-48, HHS publication no. (SMA) 14-4863 2014, Substance Abuse and Mental Health Services Administration, Rockville, MD.
20. Turner B.J., Laine C., Lin Y., Lynch K. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence. Archives of Internal Medicine 2005, 165(15):1769-1776.
21. Wagner E.H., Austin B.T., Davis C., Hindmarsh M., Schaefer J., Bonomi A. Improving chronic illness care: Translating evidence into action. Health Affairs (Project Hope) 2001, 20(6):64-78.
22. Walley A.Y., Alperen J.K., Cheng D.M., Botticelli M., Castro-Donlan C., Samet J.H., et al. Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers. Journal of General Internal Medicine 2008, 23(9):1393-1398.
23. Wesson D.R., Ling W. The clinical opiate withdrawal scale (COWS). Journal of Psychoactive Drugs 2003, 35(2):253-259.